Results 81 to 90 of about 51,706 (265)

Biomarkers in bronchiectasis

open access: yesEuropean Respiratory Review
Bronchiectasis is a heterogeneous disease with multiple aetiologies and diverse clinical features. There is a general consensus that optimal treatment requires precision medicine approaches focused on specific treatable disease characteristics, known as ...
Emma D. Johnson   +2 more
semanticscholar   +1 more source

Preliminary Development of a Patient‐Reported Outcome Measure for Inducible Laryngeal Obstruction: Findings From a Delphi Process

open access: yesRespirology, EarlyView.
Currently there are few patient‐reported outcome measures for inducible laryngeal obstruction which characterise the multidimensional impact of the disease. The Delphi survey identified which items were important to include from a patient and health care professional perspective.
Siobhan Ludlow   +3 more
wiley   +1 more source

Active Cycle of Breathing Technique Versus Oscillating Positive Expiratory Pressure Therapy Versus Exercise With Huffing During an Exacerbation of Bronchiectasis: A Randomised, Controlled Trial

open access: yesRespirology, EarlyView.
Walking with huffing and the active cycle of breathing technique produced similar improvements in sputum expectoration and quality‐of‐life during hospitalisation for individuals experiencing a bronchiectasis exacerbation, while oscillating positive‐expiratory‐pressure therapy produced minimal changes.
Jennifer Phillips   +5 more
wiley   +1 more source

Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)

open access: yesEuropean Respiratory Journal
Extract Bronchiectasis is a chronic inflammatory disease [1, 2]. Although it is recognised that bronchiectasis is composed of multiple phenotypes and endotypes, inflammation has classically been regarded as neutrophilic and patients with higher levels of
S. Aliberti   +40 more
semanticscholar   +1 more source

Lung V5 and Planning Target Volume/Lung Volume Ratio as Independent Risk Factors for ≥Grade 2 Radiation Pneumonitis after Moderately Hypofractionated Radiotherapy: A Retrospective Study

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
Lung V5 and the planning target volume/lung volume ratio were identified as independent dosimetric risk factors for clinically significant radiation pneumonitis following moderately hypofractionated radiotherapy for lung cancer. Maintaining V5 < 35% may help mitigate this risk in clinical practice.
YuanYou Yang   +3 more
wiley   +1 more source

What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey

open access: yesERJ Open Research, 2021
Michal Shteinberg   +14 more
doaj   +1 more source

Severe bronchiectasis is associated with increased carotid intima-media thickness

open access: yesBMC Cardiovascular Disorders
Background Although bronchiectasis has been shown to be associated with cardiovascular disease, there is limited evidence of an association with subclinical atherosclerosis, especially carotid intima-media thickness (CIMT). Methods This prospective study
Wang Chun Kwok   +9 more
doaj   +1 more source

CLINICO–Demographic Profile and Outcomes of Hospitalised Children With Diphtheria in A Tertiary Care Hospital of Peshawar

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim To determine the clinico‐demographic profile and predictors of mortality in hospitalised children with diphtheria. Methods This retrospective cohort study included 202 children aged 5–16 years diagnosed with diphtheria per WHO criteria at Lady Reading Hospital, Peshawar, from January 2023 to December 2024. Data on demographics, vaccination
Amir Muhammad   +6 more
wiley   +1 more source

High-sensitivity C-reactive protein level in stable-state bronchiectasis predicts exacerbation risk

open access: yesBMC Pulmonary Medicine
Background Elevation of systemic inflammatory markers were found to correlate with increased disease extent, reduced lung function and higher risk of future severe exacerbations in patients with bronchiectasis.
Wang Chun Kwok   +3 more
doaj   +1 more source

Asthma and Multimorbidity Amongst Ethnic Minority Groups in High Income Countries

open access: yesClinical &Experimental Allergy, EarlyView.
There is a tight intersection between asthma, deprivation, ethnicity, multimorbidity and poor clinical outcomes. An integrated, holistic and culturally tailored approach is needed to improve clinical outcomes amongst ethnic minority groups with asthma and multimorbidity. ABSTRACT Asthma is one of the commonest noncommunicable diseases worldwide.
Mamidipudi Thirumala Krishna   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy